top of page

dillon corvino

A Bit About Me

I'm a tumor immunologist studying NK cells who is passionate about open access research, genetic barcoding, genetic engineering, and mathematical modeling.

  • Twitter
  • icons8-github-384
  • icons8-google-scholar-384
  • LinkedIn

About Me.

I was born and raised in Australia and graduated with my Ph.D in 2019 with a thesis in tumor immunology. My thesis focused on improving adoptive T-cell therapy targeting virus-associated cancers. 

In 2020, I was recruited to the Institut für Experimentelle Onkologie (IEO) at the Universitätsklinikum Bonn, Germany, by Prof. Michael Hölzel. I now work in the research group of Prof. Tobias Bald who is a W2 professor within the IEO. 

Currently, I am leveraging single cell sequencing technologies, genetic barcoding, and genetic engineering approaches to explore tumor NK cell immunology. I am passionate about the therapeutic potential of targeted genetic engineering of primary cells. As well as, fascinated by the understanding of fundamental immunology; which, could be unlocked by harnessing genetic barcoding and mathematical modeling. 

Follow me on twitter or message me if you are interested in collaboration or any of my work.



Apr 2015–Sep 2019

Doctor of Philosophy (PhD)
University of Queensland

Based in Prof. Rajiv Khanna's lab at QIMR Berghofer Medical Research Institute, Brisbane, Australia. Investigated approaches to manufacturing of EBV-specific autologous and allogeneic T-cells. Used in vitro primary T-cell assays, multiparametic flow cytometry, RNAseq, and humanised murine models.

Feb 2011–Nov 2014

Bachelor of Science (Honours, Class I)
Griffith University

During my bachelors I undertook a number of undergraduate research projects with mentors such as Assoc. Prof. Derek Kennedy and Assoc. Prof. Jeremy Brownlie where I learned fundemental molecular biology techniques and dabbled with drosophila research. 

My honours year was spent in the lab of Prof. Nicholas Hayward where I explored predicting and validating tumor neoantigens from patient-derived melanoma material


  • Twitter
  • icons8-github-384
  • icons8-google-scholar-384
  • LinkedIn

Thanks for submitting!

This form no longer accepts submissions.

bottom of page